IE35419L - Pharmaceutical composition containing cyclobenzaprine - Google Patents

Pharmaceutical composition containing cyclobenzaprine

Info

Publication number
IE35419L
IE35419L IE710845A IE84571A IE35419L IE 35419 L IE35419 L IE 35419L IE 710845 A IE710845 A IE 710845A IE 84571 A IE84571 A IE 84571A IE 35419 L IE35419 L IE 35419L
Authority
IE
Ireland
Prior art keywords
pharmaceutical composition
composition containing
july
cyclobenzaprine
acid addition
Prior art date
Application number
IE710845A
Other versions
IE35419B1 (en
Original Assignee
Frosst & Co Charles E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frosst & Co Charles E filed Critical Frosst & Co Charles E
Publication of IE35419L publication Critical patent/IE35419L/en
Publication of IE35419B1 publication Critical patent/IE35419B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1337068 Skeletal muscle relaxants CHARLES E FROSST & CO 5 July 1971 [7 July 1970] 31334/71 Heading ASB Pharmaceutical dosage units having skeletal muscle relaxant activity comprise (a) 1-25 mg of cyclobenzaprine or an acid addition salt thereof and (b) a carrier. The acid addition salt may be the hydrochloride. The dosage unit may be a tablet for oral administration or an injectable solution in sterile water. [GB1337068A]
IE845/71A 1970-07-07 1971-07-01 Muscle-relaxant compositions IE35419B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA87562 1970-07-07

Publications (2)

Publication Number Publication Date
IE35419L true IE35419L (en) 1972-01-07
IE35419B1 IE35419B1 (en) 1976-02-04

Family

ID=4087146

Family Applications (1)

Application Number Title Priority Date Filing Date
IE845/71A IE35419B1 (en) 1970-07-07 1971-07-01 Muscle-relaxant compositions

Country Status (15)

Country Link
BE (1) BE769517A (en)
CA (1) CA958643A (en)
CY (1) CY885A (en)
FR (1) FR2100873B1 (en)
GB (1) GB1337068A (en)
HK (1) HK4077A (en)
IE (1) IE35419B1 (en)
IL (1) IL37173A (en)
KE (1) KE2690A (en)
MT (1) MTP698B (en)
MY (1) MY7700127A (en)
NL (1) NL7108745A (en)
PH (1) PH12038A (en)
ZA (1) ZA713719B (en)
ZM (1) ZM9571A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2109268T3 (en) * 1990-05-18 1998-01-16 Merrell Pharma Inc 5H-DIBENZO (A, D) CYCLLOHEPTENES USED AS MUSCARINIC RECEPTOR ANTAGONISTS.
US5508280A (en) * 1990-05-18 1996-04-16 Merrell Pharmaceuticals, Inc. 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
AR025111A1 (en) 1999-08-13 2002-11-06 Janus Pharmaceuticals Inc METHODS AND COMPOSITIONS TO TREAT GENERALIZED ANXIETY DISORDERS
BR0013017A (en) 1999-08-13 2002-04-16 Vela Pharmaceuticals Inc Uses of compositions for the treatment or prevention of sleep disorders using very low doses of cyclobenzaprine
ITMI20110558A1 (en) * 2011-04-06 2012-10-07 Campiglio Consulting Srl PHARMACEUTICAL COMPOSITION CONTAINING CYCLOBENZAPRINE SUITABLE FOR ENDONASAL ADMINISTRATION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454643A (en) * 1959-04-27 1969-07-08 Arthur C Cope 5 - (tertiaryaminoalkylene)-5 hydroxy- and 5-(tertiary aminoalkylidene) - dibenzocycloheptatrienes,and salts thereof

Also Published As

Publication number Publication date
MY7700127A (en) 1977-12-31
CA958643A (en) 1974-12-03
FR2100873B1 (en) 1974-08-02
PH12038A (en) 1978-10-16
ZM9571A1 (en) 1973-04-24
BE769517A (en) 1972-01-05
NL7108745A (en) 1972-01-11
CY885A (en) 1977-03-18
HK4077A (en) 1977-01-28
IL37173A0 (en) 1971-08-25
ZA713719B (en) 1973-01-31
GB1337068A (en) 1973-11-14
FR2100873A1 (en) 1972-03-24
KE2690A (en) 1977-01-28
IL37173A (en) 1975-02-10
MTP698B (en) 1971-11-03
IE35419B1 (en) 1976-02-04

Similar Documents

Publication Publication Date Title
Brand et al. Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
IL53596A (en) Biological cells externally modified for controlled release,in the spleen and/or liver,of pharmaceutically active substances comprised therein,their preparation and pharmaceutical compositions containing them
GB1310658A (en) Composition and method for treatment of hepatic disease and mental fatugue
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
GB1202148A (en) Pharmaceutical compositions
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
GB1442159A (en) Pharmaceutical compositions containing paracetamol
GB1118606A (en) Compositions for the treatment of haemorrhoids
GB1375806A (en)
GB1327560A (en) Effervescent pharmaceutical preparations
GB1327464A (en) Pharmaceutical composition for inhibiting indoleamine-n- methyl transferase
GB1357813A (en) Effervescent composition for the treatment of heart diseases
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
GB1293329A (en) Pharmaceutical compositions
GB1287433A (en) Pharmaceutical compositions
AU474505B2 (en) Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
GB1454390A (en) Nasal decongestants
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GB1279185A (en) Improvements in or relating to pharmaceutical compositions
JPS57179118A (en) Antitumor agent
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
Jirgl et al. The influence of propericiazine on the behavior of difficult delinquents.